About Flamel Technologies
Flamel Technologies is a company based in Venissieux (France) founded in 1990 by Gerard Soula was acquired by Recipharm in November 2014. Flamel Technologies has completed 1 acquisition, including FSC Pediatrics.
- Headquarter Venissieux, France
- Founders Gerard Soula
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Flamel Technologies
Investors in Flamel Technologies
Flamel Technologies has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Recipharm and Deerfield.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare ecosystem is supported through investment and innovation by Deerfield.
|
Locked | Locked | Locked | |
|
Pharmaceutical development and manufacturing services are offered contractually.
|
Locked | Locked | Locked |
Investor details for Flamel Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Flamel Technologies
Flamel Technologies has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include FSC Pediatrics.
Investment portfolio details for Flamel Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Pediatric healthcare services are provided in Charlotte.
|
Locked | Locked | 2004 | Locked |
Complete acquisition details for Flamel Technologies
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Flamel Technologies
Detailed financials for Flamel Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Flamel Technologies Comparisons
Peer comparison for Flamel Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Flamel Technologies
Detailed competitors of Flamel Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Flamel Technologies
Complete news archive for Flamel Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Flamel Technologies
Flamel Technologies was founded in 1990 and raised its 1st funding round 23 years after it was founded.
Flamel Technologies is headquartered in Venissieux, France. It is registered at Venissieux, Auvergne-rhone-alpes, France.
Gerard Soula is the current CEO of Flamel Technologies. They have also founded this company.
Flamel Technologies is a specialty pharmaceutical company focussed in the formulation development and drug delivery to develop pharmaceutical products. It currently has 3 drugs in the USA for anesthesia namely Bloxiverz (neostigmine methylsulfate injection), Vazculep (phenylephrine hydrochloride injection) and Akovaz (ephedrine sulfate). Using its proprietary drug delivery platforms Micropump (oral sustained release microparticles platform), LiquiTime (a Micropump-derivative platform for liquid oral products) and Trigger Lock (a Micropump-derivative platform for abuse-resistant opioids), it is also developing its pipeline for CNS respiratory disorders which include sodium oxybate, an extended-release of liquid medicines such as ibuprofen and guaifenesin and also working on the delivery of exenatide utilizing the Medusa technology for diabetes. It acquired Eclat Pharmaceuticals FSC Pediatrics in March 2012 February 2016 respectively.
Flamel Technologies has made 1 acquisition, including FSC Pediatrics.